Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Treasury’s Final Earnings Stripping Guidance Keeps Pressure On Inversions

Oct 17 2016

• By Jessica Merrill

StormuSkyWarningSign_1200x675

Related Content

US Treasury Hits Back On Inversions; Will Pfizer Fold?

Apr 05 2016

Inversion Crackdown: Does It Spell The End For Pfizer/AstraZeneca?

Oct 06 2014

The Fall Of Pfizergan: The Beginning, The End And Everything In Between

Apr 11 2016

It's The End Of Pfizergan, So Pfizer Will Have To Grow It Alone

Apr 07 2016

Death And Tax Inversion: Policy Fight Won't Go Away, Now Spawning Lawsuits

Aug 08 2016

Related Companies

Pfizer Inc.

Allergan plc

AstraZeneca PLC

AbbVie Inc.

Takeda Pharmaceutical Co. Ltd.

Additional Topics

Business Strategies Elections Commercial BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window